title: Radioresistant sensitization of neuroblastoma by cisplatin?
authors.affiliation: Division of Pediatric Oncology, Università Cattolica, Rome, Italy.
authors.forename: S
authors.initials: S
authors.lastname: Mastrangelo
authors.forename: A
authors.initials: A
authors.lastname: Tornesello
authors.forename: V
authors.initials: V
authors.lastname: Bembo
authors.forename: V
authors.initials: V
authors.lastname: Rufini
authors.forename: R
authors.initials: R
authors.lastname: Mastrangelo
mesh_terms: D019797:3-Iodobenzylguanidine / Q000008:administration & dosage*; D000310:Adrenal Gland Neoplasms / Q000188:drug therapy* / Q000473:pathology; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D002648:Child; D002945:Cisplatin / Q000008:administration & dosage*; D004334:Drug Administration Schedule; D004357:Drug Synergism; D006801:Humans; D008297:Male; D009447:Neuroblastoma / Q000188:drug therapy* / Q000473:pathology / Q000556:secondary; D011838:Radiation-Sensitizing Agents / Q000008:administration & dosage*; D019275:Radiopharmaceuticals / Q000008:administration & dosage*; D018714:Radiotherapy, Adjuvant
chemical_list: D000970:Antineoplastic Agents; D011838:Radiation-Sensitizing Agents; D019275:Radiopharmaceuticals; D019797:3-Iodobenzylguanidine; D002945:Cisplatin